Outcomes of treatment of cats with feline infectious peritonitis using parenterally administered remdesivir, with or without transition to orally administered GS‐441524

Outcomes of treatment of cats with feline infectious peritonitis using parenterally administered remdesivir, with or without transition to orally administered GS‐441524

Abstract Background Nucleoside analog GS‐441524 is effective in treating cats with feline infectious peritonitis (FIP). Investigation into the use of parent nucleotide analog remdesivir (GS‐5734) is needed. Objectives To assess efficacy and tolerability of remdesivir with or without transition to GS...

Full description

Bibliographic Details
Main Authors: Sally J. Coggins, Jacqui M. Norris, Richard Malik, Merran Govendir, Evelyn J. Hall, Benjamin Kimble, Mary F. Thompson
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:Journal of Veterinary Internal Medicine
Subjects:
antiviral
clinical trial
feline coronavirus
nucleoside analog
Online Access:https://doi.org/10.1111/jvim.16803

Internet

https://doi.org/10.1111/jvim.16803

Similar Items